Emerging lymphatic imaging technologies for mouse and man

Journal of Clinical Investigation

Volumn 124, Issue 3, 2014, Pages 905-914

  Sevick Muraca, Eva M ^a   Kwon, Sunkuk ^a   Rasmussen, John C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; HEMODYNAMICS; HUMAN; IMMUNOSURVEILLANCE; IN VIVO STUDY; LIPID ABSORPTION; LONGITUDINAL STUDY; LYMPH VESSEL; LYMPHOSCINTIGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GREEN FLUORESCENT PROTEINS; HUMANS; LYMPHATIC DISEASES; LYMPHATIC VESSELS; LYMPHOGRAPHY; MAGNETIC RESONANCE IMAGING; NEOPLASMS; OPTICAL IMAGING;

EID: 84896765574     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI71612     Document Type: Review

References (119)

1. Jaffer FA, Libby P, Weissleder R. Molecular imaging of cardiovascular disease. Circulation. 2007;116(9):1052-1061.
2. Clement O, Luciani A. Imaging the lymphatic system: possibilities and clinical applications. Eur Radiol. 2004;14(8):1498-1507.
3. Sharma R, Wendt JA, Rasmussen JC, Adams KE, Marshall MV, Sevick-Muraca EM. New horizons for imaging lymphatic function. Ann N Y Acad Sci. 2008;1131:13-36.
4. Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL. New approaches to lymphatic imaging. Lymphat Res Biol. 2009;7(4):205-214.
5. Zhang F, Niu G, Lu G, Chen X. Preclinical lymphatic imaging. Mol Imaging Biol. 2011;13(4):599-612.
6. Proulx ST, Detmar M. Molecular mechanisms imaging of lymphatic metastasis. Exp Cell Res. 2013;S0014-4827
7. Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin. 2006;56(5):292-309.
8. Liu N, Wang C, Sun M. Noncontrast three-dimensional magnetic resonance imaging vs lymphoscintigraphy in the evaluation of lymph circulation disorders: A comparative study. J Vasc Surg. 2005;41(1):69-75.
9. Kinmonth JB. Lymphangiography in man; a method of outlining lymphatic trunks at operation. Clin Sci (Lond). 1952;11(1):13-20.
10. Mennini ML, Catalano C, Del Monte M, Fraioli F. Computed tomography and magnetic resonance imaging of the thoracic lymphatic system. Thorac Surg Clin. 2012;22(2):155-160.
11. Lohrmann C, Foeldi E, Langer M. Indirect magnetic resonance lymphangiography in patients with lymphedema preliminary results in humans. Eur J Radiol. 2006;59(3):401-406.
12. Lohrmann C, Foeldi E, Langer M. Diffuse lymphangiomatosis with genital involvement - evaluation with magnetic resonance lymphangiography. Urol Oncol. 2011;29(5):515-522.
13. Lu Q, et al. MR lymphography of lymphatic vessels in lower extremity with gynecologic oncologyrelated lymphedema. PLoS One. 2012;7(11):e50319.
14. Notohamiprodjo M, et al. MR lymphangiography at 3.0 T: correlation with lymphoscintigraphy. Radiology. 2012;264(1):78-87.
15. Kobayashi H, et al. Comparison of dendrimerbased macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med. 2003;50(4):758-766.
16. Kobayashi H, et al. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst. 2004;96(9):703-708.
17. Sena LM, et al. Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models. Nanomedicine (Lond). 2010;5(8):1183-1191.
18. Kiryu S, et al. Interstitial MR lymphography in mice: comparative study with gadofluorine 8, gadofluorine M, and gadofluorine P. Magn Reson Med Sci. 2012;11(2):99-107.
19. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44(1):43-57.
20. Scarsbrook AF, Ganeshan A, Bradley KM. Pearls and pitfalls of radionuclide imaging of the lymphatic system. Part 2: evaluation of extremity lymphoedema. Br J Radiol. 2007;80(951):219-226.
21. Zimmerman H, Fessa CK, Rossleigh MA, Wegner EA. Lymphoscintigraphy of lower limb edema. Clin Nucl Med. 2012;37(4):411-415.
22. Tartaglione G, et al. Intradermal lymphoscintigraphy at rest and after exercise: a new technique for the functional assessment of the lymphatic system in patients with lymphoedema. Nucl Med Commun. 2010;31(6):547-551.
23. Modi S, Stanton AW, Mortimer PS, Levick JR. Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy. Lymphat Res Biol. 2007;5(3):183-202.
24. Leu AJ, Berk DA, Yuan F, Jain RK. Flow velocity in the superficial lymphatic network of the mouse tail. Am J Physiol. 1994;267(4 pt 2):H1507-H1513.
25. Leu AJ, et al. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 2000;60(16):4324-4327.
26. Bollinger A, Jäger K, Sgier F, Seglias J. Fluorescence microlymphography. Circulation. 1981; 64(6):1195-1200.
27. Stanton AW, Kadoo P, Mortimer PS, Levick JR. Quantification of the initial lymphatic network in normal human forearm skin using fluorescence microlymphography and stereological methods. Microvasc Res. 1997;54(2):156-163.
28. Mellor RH, et al. Enhanced cutaneous lymphatic network in the forearms of women with postmastectomy oedema. J Vasc Res. 2000;37(6):501-512.
29. Bollinger A, Amann-Vesti BR. Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity. Lymphology. 2007;40(2):52-62.
30. Jonak C, et al. Intradermal indocyanine green for in vivo fluorescence laser scanning microscopy of human skin: a pilot study. PLoS One. 2011;6(8):e23972.
31. Polom K, et al. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer. 2011;117(21):4812- 4822.
32. Schaafsma BE, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104(3):323-332.
33. Sevick-Muraca EM. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med. 2012;63:217-231.
34. Zhu B, Rasmussen JC, Sevick-Muraca EM. A matter of collection and detection for intraoperative and noninvasive near-infrared fluorescence molecular imaging: To see or not to see? Med Physic. 2014;41:022105. doi:10.1118/1.4862514.
35. Marshall MV, et al. Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update. Open Surg Oncol J. 2010;2(2):12-25.
36. Sevick-Muraca EM, et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology. 2008;246(3):734-741.
37. Kwon S, Sevick-Muraca EM. Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol. 2007;5(4):219-231.
38. Kwon S, Sevick-Muraca EM. Mouse phenotyping with near-infrared fluorescence lymphatic imaging. Biomed Opt Express. 2011;2(6):1403-1411.
39. Kwon S, et al. Direct visualization of changes of lymphatic function and drainage pathways in lymph node metastasis of B16F10 melanoma using near-infrared fluorescence imaging. Biomed Opt Express. 2013;4(6):967-977.
40. Rasmussen JC, et al. Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol. 2009;20(1):74-82.
41. Mihara M, et al. Predictive lymphatic mapping: a method for mapping lymphatic channels in patients with advanced unilateral lymphedema using indocyanine green lymphography [published online ahead of print March 12, 2013]. Ann Plast Surg. doi:10.1097/SAP.0b013e31826a18b1.
42. Mihara M, et al. Lower limb lymphedema treated with lymphatico-venous anastomosis based on preand intraoperative icg lymphography and non-contact vein visualization: a case report. Microsurgery. 2012;32(3):227-230.
43. Mihara M, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS One. 2012;7(6):e38182.
44. Buretta KJ, et al. Near-infrared lymphography as a minimally invasive modality for imaging lymphatic reconstitution in a rat orthotopic hind limb transplantation model. Transpl Int. 2013;26(9):928-937.
45. Sharma R, et al. Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol. 2007; 292(6):H3109-H3118.
46. Unno N, et al. A novel method of measuring human lymphatic pumping using indocyanine green fluorescence lymphography. J Vasc Surg. 2010; 52(4):946-952.
47. Muthuchamy M, Zawieja D. Molecular regulation of lymphatic contractility. Ann N Y Acad Sci. 2008;1131:89-99.
48. Stout Gergich NL, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809- 2819.
49. Rasmussen JC, Kwon S, Sevick-Muraca EM, Cormier JN. The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging. Ann Biomed Eng. 2012;40(2):408-421.
50. Kwon S, Sevick-Muraca EM. Functional lymphatic imaging in tumor-bearing mice. J Immunol Methods. 2010;360(1-2):167-172.
51. Gogineni A, et al. Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis. PLoS One. 2013;8(7):e68755.
52. Proulx ST, et al. Use of a PEG-conjugated bright nearinfrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis. Biomaterials. 2013;34(21):5128-5137.
53. Tan IC, et al. Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging. Arch Phys Med Rehabil. 2011;92(5):756-764 e751.
54. Oremus M, Walker K, Dayes I, Raina P. Diagnosis and treatment of secondary lymphedema. technology assessment report. Baltimore, Maryland, USA: Medicare Evidence Development & Coverage Advisory Committee meeting, Centers for Medicare & Medicaid Services; November 18, 2009. Report No.: Project ID: LYMT0908.
55. Robinson HA, et al. Non-invasive optical imaging of the lymphatic vasculature of a mouse. J Vis Exp. 4326;2013(73):e4326.
56. Kwon S, Agollah GD, Chan W, Sevick-Muraca EM. Altered lymphatic function and architecture in salt-induced hypertension assessed by near-infrared fluorescence imaging. J Biomed Opt. 2012;17(8):080504-080501.
57. Zhou Q, et al. Near-infrared lymphatic imaging demonstrates the dynamics of lymph flow and lymphangiogenesis during the acute versus chronic phases of arthritis in mice. Arthritis Rheum. 2010;62(7):1881-1889.
58. Li J, et al. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. Arthritis Rheum. 2013;65(1):130-138.
59. Aldrich MB, Sevick-Muraca EM. Cytokines are systemic effectors of lymphatic function in acute inflammation. Cytokine. 2013;64(1):362-369.
60. Hall MA, Robinson H, Chan W, Sevick-Muraca EM. Detection of lymphangiogenesis by nearinfrared fluorescence imaging and responses to VEGF-C during healing in a mouse full-dermis thickness wound model. Wound Repair Regen. 2013; 21(4):604-615.
61. Liao S, et al. Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A. 2011;108(46):18784-18789.
62. Dixon JB. Mechanisms of chylomicron uptake into lacteals. Ann N Y Acad Sci. 2010;1:E52-E57.
63. Kindel T, Lee DM, Tso P. The mechanism of the formation and secretion of chylomicrons. Atheroscler Suppl. 2010;11(1):11-16.
64. Kassis T, et al. Dual-channel in-situ optical imaging system for quantifying lipid uptake and lymphatic pump function. J Biomed Opt. 2012;17(8):086005.
65. Harvey NL, et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adultonset obesity. Nat Genet. 2005;37(10):1072-1081.
66. Jeon BH, et al. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res. 2008;68(4):1100-1109.
67. Ribera J, et al. Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut. 2013;62(1):138-145.
68. Shackcloth MJ, Poullis M, Lu J, Page RD. Preventing of chylothorax after oesophagectomy by routine pre-operative administration of oral cream. Eur J Cardiothorac Surg. 2001;20(5):1035-1036.
69. Cope C, Kaiser LR. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol. 2002;13(11):1139-1148.
70. Nadolski GJ, Itkin M. Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Chest. 2013;143(1):158-163.
71. Parvinian A, et al. Ultrasound-guided intranodal lymphangiography followed by thoracic duct embolization for treatment of post-operative bilateral chylothorax. Head Neck. 2014;36(2):E21-E24.
72. Ashitate Y, et al. Near-infrared fluorescence imaging of thoracic duct anatomy and function in open surgery and video-assisted thoracic surgery. J Thorac Cardiovasc Surg. 2011;142(1):31-32.
73. Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H. In vivo real-time lymphatic draining using quantum-dot optical imaging in mice. Contrast Media Mol Imaging. 2013;8(1):96-100.
74. Davies-Venn CA, et al. Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging. Mol Imaging Biol. 2012;14(3):301-314.
75. Laakkonen P, Porkka K, Hoffman JA, Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med. 2002;8(7):751-755.
76. Banerji S, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144(4):789-801.
77. McElroy M, et al. Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J Surg Res. 2009;151(1):68-73.
78. Mumprecht V, Detmar M. In vivo imaging of lymph node lymphangiogenesis by immunopositron emission tomography. Methods Mol Biol. 2013;961:129-140.
79. Guo Q, et al. Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles. Int J Nanomedicine. 2013;8:2273-2284.
80. Baumjohann D, et al. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur J Immunol. 2006;36(9):2544-2555.
81. Choi I, et al. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood. 2011;117(1):362-365.
82. Hagerling R, et al. Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochem Soc Trans. 2011;39(6):1674-1681.
83. Truman LA, et al. ProxTom lymphatic vessel reporter mice reveal Prox1 expression in the adrenal medulla, megakaryocytes, and platelets. Am J Pathol. 2012;180(4):1715-1725.
84. Martinez-Corral I, et al. In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proc Natl Acad Sci U S A. 2012;109(16):6223-6228.
85. Shu X, et al. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science. 2009;324(5928):804-807.
86. Shcherbakova DM, Verkhusha VV. Near-infrared fluorescent proteins for multicolor in vivo imaging. Nat Methods. 2013;10(8):751-754.
87. Lu Y, et al. In vivo imaging of orthotopic prostate cancer with far-red gene reporter fluorescence tomography and in vivo and ex vivo validation. J Biomed Opt. 2013;18(10):101305.
88. Lapinski PE, et al. RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice. J Clin Invest. 2012;122(2):733-747.
89. Burrows PE, et al. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. Proc Natl Acad Sci U S A. 2013; 110(21):8621-8626.
90. Karlsen TV, et al. Minimally invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin. Am J Physiol Heart Circ Physiol. 2012;302(2):H391-H401.
91. Bollinger A, Isenring G, Franzeck UK, Brunner U. Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphedema (Milroy's disease). Lymphology. 1983;16(1):27-30.
92. Karkkainen MJ, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 2001;98(22):12677-12682.
93. Tammela T, et al. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med. 2007;13(12):1458-1466.
94. Vahrmeijer AL, et al. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013;10(9):507-518.
95. Vera DR, Wallace AM, Hoh CK, Mattrey RF. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. J Nucl Med. 2001;42(6):951-959.
96. Sondak VK, et al. Combined analysis of phase III trials evaluating [(9)(9)mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol. 2013;20(2):680-688.
97. Emerson DK, et al. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012;265(1):186-193.
98. Ting R, et al. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug Chem. 2010;21(10):1811-1819.
99. Kim S, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol. 2004;22(1):93-97.
100. Kobayashi H, et al. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release. 2006;111(3):343-351.
101. Song KH, Kim C, Maslov K, Wang LV. Noninvasive in vivo spectroscopic nanorod-contrast photoacoustic mapping of sentinel lymph nodes. Eur J Radiol. 2009;70(2):227-231.
102. Elias A,Tsourkas A. Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles. Hematology Am Soc Hematol Educ Program. 2009;720-726.
103. Harisinghani MG, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491-2499.
104. Sabach AS, et al. Gadofosveset trisodium: abdominal and peripheral vascular applications. AJR Am J Roentgenol. 2013;200(6):1378-1386.
105. Schipper RJ, et al. Noninvasive nodal staging in patients with breast cancer using gadofosvesetenhanced magnetic resonance imaging: a feasibility study. Invest Radiol. 2013;48(3):134-139.
106. Hall MA, et al. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF. J Nucl Med. 2012;53(9):1427-1437.
107. Heath CH, et al. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol Head Neck Surg. 2013;148(6):982-990.
108. Fischman AJ, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med. 1990;31(7):1199-1205.
109. Farina KL, et al. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res. 1998;58(12):2528-2532.
110. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438(7070):946-953.
111. Meric-Bernstam F, et al. Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents. Biomed Opt Express. 2014;5(1):183-196.
112. Kinmonth JB, Taylor GW, Lee RH. Arteriol replacement by orlon cloth; a preliminary report of its experimental and clinical use. Br Med J. 1955;1(4927):1406-1409.
113. Kos S, Haueisen H, Lachmund U, Roeren T. Lymphangiography: forgotten tool or rising star in the diagnosis and therapy of postoperative lymphatic vessel leakage. Cardiovasc Intervent Radiol. 2007;30(5):968-973.
114. Partsch H, Urbanek A, Wenzel-Hora B. The dermal lymphatics in lymphoedema visualized by indirect lymphography. Br J Dermatol. 1984;110(4):431-438.
115. Suga K, Ogasawara N, Okada M, Matsunaga N. Interstitial CT lymphography-guided localization of breast sentinel lymph node: preliminary results. Surgery. 2003;133(2):170-179.
116. Suga K, et al. Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience. Radiology. 2004;230(2):543-552.
117. Kobayashi H, et al. Micro-magnetic resonance lymphangiography in mice using a novel dendrimerbased magnetic resonance imaging contrast agent. Cancer Res. 2003;63(2):271-276.
118. Liu NF, et al. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography. J Vasc Surg. 2009;49(4):980-987.
119. Liu NF, Yan ZX, Wu XF. Classification of lymphatic system malformations in primary lymphoedema based on MR lymphangiography. Eur J Vasc Endovasc Surg. 2012;44(3):345-349.